September 17th 2024
Your daily dose of the clinical news you may have missed.
September 12th 2024
Advances In™: Aligning Pathology and Oncology Efforts in the Community to Improve NSCLC Care
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Tumor-Infiltrating Lymphocyte Therapy Advances Into Melanoma
View More
Community Practice Connections™: 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Squamous Cell Carcinoma of the Penis
December 5th 2012There is a rather large erythematous patch/plaque present. However, an exophytic, verrucous nodule is visible at the inferior border of the tumor. Biopsy of the flatter portion of this lesion disclosed squamous cell carcinoma in-situ, while biopsy of the nodule revealed invasive squamous cell carcinoma.
Post-traumatic Subcutaneous Hematoma
November 9th 2012This large bruise developed after the patient had an accident in her yard. Post-traumatic subcutaneous hematomas are common in elderly women, especially those who are anticoagulated. Untreated, the hematoma can eventuate into an abscess and even sepsis.
Malignant Melanoma on a Patient’s Back
October 23rd 2012The only impressive thing about this lesion was a “notch” in its superior pole, and some mild pigment heterogeneity. Prudent caution proved extremely beneficial. The history of a “new” lesion in a patient with almost no visible nevi, along with some very subtle gross features, led to early recognition and elimination of a malignant melanoma.
Dermatophytosis (Tinea) That Resembles Necrobiosis Lipoidica
October 15th 2012Always check the toenails for fungal infection after diagnosing tinea pedis, corporis, or cruris. The toenails may act as the source of infection and a reservoir, which may lead to reinfection after the cutaneous dermatophytosis is cleared.
Figurate Erythema-A Reactional (Hypersensitivity) State
September 19th 2012The differential diagnosis includes figurate erythema, granuloma annulare, sarcoidosis, and Hansen’s disease. Additional history disclosed that the plaques expanded, migrated and disappeared over a matter of days, eliminating all but the correct diagnosis: figurate erythema, a reactional (hypersensitivity) state.
Pyoderma Gangrenosum on the Leg of a Woman With Seropositive Rheumatoid Arthritis
September 11th 2012The location (pretibial surface) of this ulcer, its visibly rolled undermined border, and severe pain are all typical of pyoderma gangrenosum, which is typically associated with inflammatory bowel disease, rheumatoid arthritis, and hematologic malignancies.
Bullous Pemphigoid: An Autoimmune Blistering Disorder
August 31st 2012In older persons, tense blisters such as these are most likely bullous pemphigus, an autoimmune blistering disease. Biopsy as well as direct and indirect immunofluorescent tests may be needed to exclude other blistering diseases, such as pemphigus and epidermolysis bullosa.